Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Some maize lines resist stalk rot better due to specific genes and enzyme activities.

Machine learning is effective in predicting gene functions and their relationships with diseases.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Circadian rhythms are crucial for stem cell function and tissue repair, and understanding them may improve aging and regeneration treatments.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Vitamin A affects hair loss and immune response in alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.